Company: PSTV
Filing Date: 2025-03-14
Form Type: PRE 14A
Source: 0001140361-25-008857
Chunk: 8

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-14
Form: PRE 14A
Chunk 8
---
 the Special Meeting on the Record Date will constitute a quorum, permitting our stockholders to conduct business at the Special Meeting. We will include abstentions and broker non-votes in the calculation of the number of shares considered to be present at the meeting for purposes of determining the presence of a quorum at the meeting. As of the Record Date, there were 11,785,078 shares of our Common Stock outstanding. If a quorum is not present to transact business at the Special Meeting or if we do not receive sufficient votes in favor of the proposals by the date of the Special Meeting, the persons named as proxies may propose one or more adjournments of the Special Meeting to permit the solicitation of additional proxies. The chairperson of the Special Meeting shall have the power to adjourn the Special Meeting. What are broker non-votes? Broker non-votes occur when nominees, such as banks and brokers holding shares on behalf of beneficial owners, do not receive voting instructions from the beneficial owners at least ten days before the Special Meeting. If you do not give your broker or other nominee voting instructions with respect to Proposal 1 (Reverse Stock Split Proposal), Proposal 2 (Issuance Proposal), Proposal 3 (Authorized Common Stock Increase Proposal), Proposal 4 (Warrant Amendment Proposal) or Proposal 5 (Adjournment Proposal), your broker or other nominee will not be able to vote on that proposal. How many votes are needed for the proposals to pass? The proposals to be voted on at the Special Meeting have the following voting requirements:

| • | Proposal 1 (Reverse Stock Split Proposal): The affirmative vote of a majority of the outstanding shares of Common Stock entitled to vote on this proposal is required to approve the Reverse Stock Split Proposal. For purposes of the Reverse Stock Split Proposal, abstentions and broker non-votes will have the effect of a vote “AGAINST” this proposal. |

| • | Proposal 2 (Issuance Proposal): The affirmative vote of a majority of the Common Stock having voting power present, virtually or by proxy, is required to approve the Issuance Proposal. For purposes of the vote on the Issuance Proposal, abstentions are considered shares present and entitled to vote and thus will have the effect of a vote “AGAINST” this proposal. Broker non-votes will have no effect on the results of the vote. |

| • | Proposal 3 (Authorized Common Stock Increase Proposal): The affirmative vote of a majority of the outstanding shares of Common Stock entitled to vote